Phase I study of the angiogenesis inhibitor BIBF 1120 in patients with advanced solid tumors. (Q34089525)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I study of the angiogenesis inhibitor BIBF 1120 in patients with advanced solid tumors. |
scientific article |
Statements
Phase I study of the angiogenesis inhibitor BIBF 1120 in patients with advanced solid tumors (English)
Klaus Mross
Martin Stefanic
Daniela Gmehling
Annette Frost
Franziska Baas
Clemens Unger
Jürgen Henning
Birgit Gaschler-Markefski
Peter Stopfer
Lothar de Rossi
22 December 2009